Vanguard Group Inc. Has $416.18 Million Stake in ICU Medical, Inc. (NASDAQ:ICUI)

Vanguard Group Inc. raised its holdings in ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 0.7% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 2,682,065 shares of the medical instruments supplier's stock after purchasing an additional 17,805 shares during the quarter. Vanguard Group Inc. owned approximately 10.96% of ICU Medical worth $416,176,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in ICUI. FMR LLC lifted its holdings in ICU Medical by 2,676.6% during the 3rd quarter. FMR LLC now owns 104,094 shares of the medical instruments supplier's stock worth $18,968,000 after buying an additional 100,345 shares in the last quarter. State Street Corp grew its stake in ICU Medical by 9.3% in the third quarter. State Street Corp now owns 907,607 shares of the medical instruments supplier's stock valued at $165,384,000 after acquiring an additional 77,506 shares during the period. Raymond James Financial Inc. bought a new stake in ICU Medical during the 4th quarter worth approximately $10,003,000. Geode Capital Management LLC increased its position in shares of ICU Medical by 9.6% during the third quarter. Geode Capital Management LLC now owns 546,954 shares of the medical instruments supplier's stock worth $99,687,000 after acquiring an additional 48,106 shares in the last quarter. Finally, Proficio Capital Partners LLC bought a new position in ICU Medical during the 4th quarter worth about $5,779,000. 96.10% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on ICUI shares. Raymond James set a $97.00 price target on shares of ICU Medical in a research note on Wednesday, March 12th. Jefferies Financial Group upgraded ICU Medical from a "hold" rating to a "buy" rating and set a $200.00 price objective on the stock in a research note on Wednesday, December 11th. Finally, StockNews.com raised shares of ICU Medical from a "hold" rating to a "buy" rating in a report on Friday. One investment analyst has rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the stock presently has an average rating of "Buy" and a consensus target price of $168.67.

Remove Ads

ICU Medical Price Performance

Shares of NASDAQ ICUI traded up $2.93 during midday trading on Monday, reaching $142.25. The company's stock had a trading volume of 437,024 shares, compared to its average volume of 266,368. The company has a market cap of $3.49 billion, a P/E ratio of -31.13 and a beta of 0.86. ICU Medical, Inc. has a fifty-two week low of $93.36 and a fifty-two week high of $196.26. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.03 and a current ratio of 2.29. The business's 50 day moving average price is $151.03 and its two-hundred day moving average price is $162.18.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.